Molecular pathophysiology of Parkinson's disease.
暂无分享,去创建一个
Andrew B West | T. Dawson | V. Dawson | A. West | Darren J Moore | Valina L Dawson | Ted M Dawson | D. Moore
[1] L. Defebvre,et al. Linkage exclusion in French families with probable Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[2] Li Zhang,et al. A missense mutation (L166P) in DJ‐1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo‐oligomerization , 2003, Journal of neurochemistry.
[3] M. Farrer,et al. Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein , 2000 .
[4] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Trojanowski,et al. Selective Insolubility of α-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model , 2001 .
[6] P. Auluck,et al. Pharmacological prevention of Parkinson disease in Drosophila , 2002, Nature Medicine.
[7] P. Lockhart,et al. DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function , 2004, Journal of Medical Genetics.
[8] Hong Jiang,et al. Mutations in NR4A2 associated with familial Parkinson disease , 2003, Nature Genetics.
[9] E. Masliah,et al. α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress , 2000 .
[10] G. Wooten,et al. Maternal inheritance in Parkinson's disease , 1997, Annals of neurology.
[11] N. Hattori,et al. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.
[12] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[13] MoonHee Lee,et al. Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult , 2001 .
[14] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] Vincenzo Bonifati,et al. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson’s disease , 2004, Journal of Molecular Medicine.
[16] P. Lansbury,et al. Neurodegenerative disease: Amyloid pores from pathogenic mutations , 2002, Nature.
[17] D. Perl,et al. Lewy-body formation is an aggresome-related process: a hypothesis , 2004, The Lancet Neurology.
[18] D. Goldstein,et al. UCHL1 is a Parkinson's disease susceptibility gene. , 2004 .
[19] J. Feldon,et al. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Abeliovich,et al. Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity , 2003, Neuron.
[21] Joachim Klose,et al. Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.
[22] Hideo Fujiwara,et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. , 2002, The Journal of clinical investigation.
[23] R. Kopito,et al. Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.
[24] D. Price,et al. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.
[25] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[26] J. Langston,et al. Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.
[27] A. Matouschek,et al. Aggregated and Monomeric α-Synuclein Bind to the S6′ Proteasomal Protein and Inhibit Proteasomal Function* , 2003, The Journal of Biological Chemistry.
[28] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[29] M. Farrer,et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease , 1999, Neurology.
[30] C. Ward,et al. Parkinson's disease in 65 pairs of twins and in a set of quadruplets , 1983, Neurology.
[31] Matthew P Frosch,et al. The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease , 2003, Neuron.
[32] V. Lee,et al. Are Ubiquitination Pathways Central to Parkinson's Disease? , 2003, Cell.
[33] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[34] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[35] John Q. Trojanowski,et al. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.
[36] J. Trojanowski,et al. Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.
[37] M. Spillantini,et al. α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome , 2001, FEBS letters.
[38] M. Polymeropoulos,et al. Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.
[39] J. Langston,et al. An electron microscopic study of MPTP-induced inclusion bodies in an old monkey , 1988, Brain Research.
[40] P. Lockhart,et al. Parkin genetics: one model for Parkinson's disease. , 2004, Human molecular genetics.
[41] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[42] Hidefumi Ito,et al. Immunocytochemical Co‐localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly , 1997, Journal of neuropathology and experimental neurology.
[43] C A Ross,et al. Synphilin‐1 is present in Lewy bodies in Parkinson's disease , 2000, Annals of neurology.
[44] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[45] R. Swerdlow,et al. Biochemical Analysis of Cybrids Expressing Mitochondrial DNA from Contursi Kindred Parkinson's Subjects , 2001, Experimental Neurology.
[46] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[47] P. Lockhart,et al. Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons , 2002, Neuron.
[48] Takeshi Iwatsubo,et al. Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective* , 2004, Journal of Biological Chemistry.
[49] Jian Feng,et al. Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation , 2003, The Journal of Neuroscience.
[50] Smita Patel,et al. Golgi Fragmentation Occurs in the Cells with Prefibrillar α-Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion* , 2002, The Journal of Biological Chemistry.
[51] S. Lindquist,et al. Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.
[52] C. Warren Olanow,et al. Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.
[53] T. Niki,et al. DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.
[54] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[55] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[56] G. Mardon,et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.
[57] T. Chase,et al. Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.
[58] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[59] E. Richfield,et al. The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.
[60] P. Brundin,et al. Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line* , 2002, The Journal of Biological Chemistry.
[61] N. Hattori,et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.
[62] A. Bentivoglio,et al. Park6‐linked parkinsonism occurs in several european families , 2002, Annals of neurology.
[63] T. Dawson,et al. Parkin-associated Parkinson’s disease , 2004, Cell and Tissue Research.
[64] John Q. Trojanowski,et al. Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro , 2003 .
[65] J. Haines,et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.
[66] H. Ischiropoulos,et al. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? , 2003, The Journal of clinical investigation.
[67] D. Goldstein,et al. The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism , 2004, Annals of neurology.
[68] Makoto Hashimoto,et al. β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.
[69] T. Sherer,et al. Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[70] T. Hashikawa,et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. , 2002, Molecular cell.
[71] Jian Feng,et al. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. , 2004, Human molecular genetics.
[72] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[73] M. Farrer,et al. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. , 1999, Neuroreport.
[74] Robert Burke,et al. Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[75] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[76] Robert Edwards,et al. Lipid Rafts Mediate the Synaptic Localization of α-Synuclein , 2004, The Journal of Neuroscience.
[77] David F. Clayton,et al. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.
[78] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[79] B. Hyman,et al. Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System , 1996, Journal of neuropathology and experimental neurology.
[80] Jeremy N. Skepper,et al. α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.
[81] K. Marder,et al. Risk of Parkinson's disease among first-degree relatives , 1996, Neurology.
[82] Hreinn Stefánsson,et al. A susceptibility gene for late‐onset idiopathic Parkinson's disease , 2002, Annals of neurology.
[83] J. Houwing-Duistermaat,et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. , 2001, American journal of human genetics.
[84] Liang Tong,et al. Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease* , 2003, Journal of Biological Chemistry.
[85] David W. Miller,et al. L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System* , 2003, Journal of Biological Chemistry.
[86] V. Uversky,et al. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.
[87] E. Hirsch,et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. , 2003, Human molecular genetics.
[88] A. Singleton,et al. Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease , 2003, Neuroscience Letters.
[89] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[90] J. Kaprio,et al. Parkinson's disease in a nationwide twin cohort , 1988, Neurology.
[91] Bruce A. Yankner,et al. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.
[92] G. Petsko,et al. The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[93] S. Tsuji,et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.
[94] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[95] Daniel R. Scoles,et al. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. , 2003, Human molecular genetics.
[96] J. Goldman,et al. Lewy bodies of Parkinson's disease contain neurofilament antigens. , 1983, Science.
[97] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[98] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[99] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[100] R. Nussbaum,et al. Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein* , 2002, The Journal of Biological Chemistry.
[101] Peter T Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.
[102] C. Ross,et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. , 2001, Human molecular genetics.
[103] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[104] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[105] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[106] A. Bentivoglio,et al. PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.
[107] P. Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.
[108] Bonifati,et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.
[109] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[110] P. Worley,et al. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.
[111] T. Niki,et al. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.
[112] J. Trojanowski,et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. , 2002, The Journal of biological chemistry.
[113] Bryan L Roth,et al. Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.
[114] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[115] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[116] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[117] Nobutaka Hattori,et al. Novel PINK1 mutations in early‐onset parkinsonism , 2004, Annals of neurology.
[118] E. Masliah,et al. Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP 1 1 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2004, Experimental Neurology.
[119] K. Lim,et al. Loss of locus coeruleus neurons and reduced startle in parkin null mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[120] Chankyu Park,et al. Crystal Structures of Human DJ-1 and Escherichia coli Hsp31, Which Share an Evolutionarily Conserved Domain* , 2003, Journal of Biological Chemistry.
[121] Santiago Canals,et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. , 2003, Human molecular genetics.
[122] P. Højrup,et al. Proteasomal Inhibition by α-Synuclein Filaments and Oligomers* , 2004, Journal of Biological Chemistry.
[123] A A Schäffer,et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. , 1997, American journal of human genetics.
[124] A A Hicks,et al. Familial aggregation of Parkinson's disease in Iceland. , 2000, The New England journal of medicine.
[125] Keith D Wilkinson,et al. Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function* , 2004, Journal of Biological Chemistry.
[126] D. Hernandez,et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. , 2003, Human molecular genetics.
[127] Nobutaka Hattori,et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. , 2005, Human molecular genetics.
[128] Christian Haass,et al. Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain , 2000, The Journal of Neuroscience.
[129] T. Dawson,et al. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders , 2001, Trends in Neurosciences.
[130] L. Seeberger,et al. Significant linkage of Parkinson disease to chromosome 2q36-37. , 2003, American journal of human genetics.
[131] Makoto Hashimoto,et al. β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[132] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[133] A. Morris,et al. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. , 1998, Biochemistry.
[134] T. Dawson,et al. Role for the ubiquitin-proteasome system in Parkinson’s disease and other neurodegenerative brain amyloidoses , 2007, NeuroMolecular Medicine.
[135] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[136] Konstantin Korotkov,et al. The 1.6-Å crystal structure of the class of chaperones represented by Escherichia coli Hsp31 reveals a putative catalytic triad , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[137] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[138] T. Kondo,et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q , 1998, Neurology.
[139] J. Trojanowski,et al. β-Synuclein gene alterations in dementia with Lewy bodies , 2004, Neurology.
[140] J. Lowe,et al. Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases , 1990, The Journal of pathology.
[141] H. Ariga,et al. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. , 2003, Biochemical and biophysical research communications.
[142] Rina Bandopadhyay,et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. , 2004, Brain : a journal of neurology.
[143] J. Trojanowski,et al. Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions* , 2002, The Journal of Biological Chemistry.
[144] R. Swerdlow,et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family , 1998, Annals of neurology.
[145] Bertram Müller-Myhsok,et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. , 2004, American journal of human genetics.
[146] Jeffrey N Keller,et al. Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.
[147] Lawrence C. Sincich,et al. The circuitry of V1 and V2: integration of color, form, and motion. , 2005, Annual review of neuroscience.
[148] K D Wilkinson,et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.
[149] H. Niznik,et al. Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[150] D. Perl,et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease , 2004, Annals of neurology.
[151] Sarah J. Tabrizi,et al. Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity , 2000 .
[152] N. Wood. Genes and parkinsonism. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[153] A. Iwamatsu,et al. Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat , 2001, Free radical research.
[154] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[155] D. Lynch,et al. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. , 2004, The Journal of biological chemistry.
[156] C. Olanow,et al. Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease , 2002, Neuroscience Letters.
[157] N. Maidment,et al. Genetics of parkin-linked disease , 2004, Human Genetics.
[158] M. Farrer,et al. α‐Synuclein promoter confers susceptibility to Parkinson's disease , 2004 .
[159] D. Maraganore,et al. UCHL1 is a Parkinson's disease susceptibility gene , 2004, Annals of neurology.
[160] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[161] Isao Nishimura,et al. Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila , 2003, Neuron.
[162] T. Dawson,et al. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. , 2003, The Journal of clinical investigation.
[163] Y. Agid,et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism , 1998, The Lancet.
[164] Todd B. Sherer,et al. An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.
[165] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[166] Christian Haass,et al. Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease , 2004, Acta Neuropathologica.
[167] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[168] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[169] R. Takahashi,et al. Pael‐R is accumulated in Lewy bodies of Parkinson's disease , 2004, Annals of neurology.
[170] L. Pallanck,et al. Parkin A Multipurpose Neuroprotective Agent? , 2003, Neuron.
[171] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[172] William T Dauer,et al. α-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons* , 2004, Journal of Biological Chemistry.
[173] J. Bell,et al. A PEDIGREE OF PARALYSIS AGITANS , 1926 .
[174] A. Bentivoglio,et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. , 2001, American journal of human genetics.
[175] D. Hernandez,et al. Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.
[176] Takeshi Iwatsubo,et al. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. , 2004, The Journal of biological chemistry.
[177] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[178] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[179] P. Lansbury,et al. The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility , 2002, Cell.
[180] Peter T. Lansbury,et al. Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.
[181] B. Müller-Myhsok,et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.
[182] J. Troncoso,et al. S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function , 2004, Science.
[183] Kaori Nishikawa,et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. , 2003, Human molecular genetics.
[184] Nancy A. Jenkins,et al. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[185] W. Gowers,et al. A Manual of Diseases of the Nervous System , 1887, Edinburgh Medical Journal.
[186] E. Hirsch,et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. , 2003, Human molecular genetics.
[187] Takayuki Harada,et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice , 1999, Nature Genetics.
[188] D W Dickson,et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology , 2004, Neurology.
[189] R. Swerdlow,et al. Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.
[190] Vladimir N Uversky,et al. A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.
[191] A. Lang,et al. Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.
[192] Patrizia Rizzu,et al. DJ‐1 colocalizes with tau inclusions: A link between parkinsonism and dementia , 2004, Annals of neurology.
[193] J. Haines,et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.